We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$401M
AUM Growth
-$4.94M
(-1.2%)
Cap. Flow
-$42.5M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
47.98%
Holding
57
New
2
Increased
14
Reduced
26
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$12.8M |
| 2 |
WEX
WEX
|
+$3.27M |
| 3 |
SEI Investments
SEIC
|
+$2.63M |
| 4 |
CDW
CDW
|
+$857K |
| 5 |
Allegion
ALLE
|
+$630K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$14.8M |
| 2 |
Johnson & Johnson
JNJ
|
+$4.56M |
| 3 |
Cisco
CSCO
|
+$3.72M |
| 4 |
Truist Financial
TFC
|
+$3.19M |
| 5 |
Kenvue
KVUE
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.13% |
| 2 | Healthcare | 16.34% |
| 3 | Financials | 14.48% |
| 4 | Consumer Staples | 12.02% |
| 5 | Consumer Discretionary | 11.76% |
Similar funds
HCM
GS
IA
WCM
PAMS
SSWG
JWM
GDS
Foyston, Gordon, & Payne's Q3 2024 Portfolio in Review
As of Q3 2024, Foyston, Gordon, & Payne held 57 positions worth $401M, down 1.2% from $406M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $42.5M in Q3 2024, closing 4 positions and reducing 26 holdings. Its most notable exit was Medtronic, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Icon worth $11.7M.
- Foyston, Gordon, & Payne's largest Q3 2024 buy was Icon: 40,624 shares worth $11.7M.
- Foyston, Gordon, & Payne added most to WEX in Q3 2024, an estimated $3.27M increase.
- Foyston, Gordon, & Payne's biggest Q3 2024 reduction was Johnson & Johnson, cutting an estimated $4.56M.
- Foyston, Gordon, & Payne fully exited Medtronic in Q3 2024, selling an estimated $14.8M.
- Foyston, Gordon, & Payne's ten largest holdings make up 48% of its $401M portfolio in Q3 2024.
- Foyston, Gordon, & Payne opened 2 new positions and closed 4 in Q3 2024.
- Foyston, Gordon, & Payne's portfolio value fell 1.2% quarter-over-quarter to $401M.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2024, filed 15 Nov 2024.